Application 103979
- Type
- BLA
- Sponsor
- GENZYME
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 103979 | Fabrazyme | agalsidase beta | 351(a) | Rx | 2026-09-01 |
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | FABRAZYME | AGALSIDASE BETA | VIAL; INTRAVENOUS | 5MG/VIAL | No | No |
| 002 | FABRAZYME | AGALSIDASE BETA | VIAL; INTRAVENOUS | 35MG/VIAL | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Fabrazyme | AGALSIDASE BETA | Genzyme Corporation | 988513ab-b06f-4dd0-93f7-d2d4531dcce4 | 2025-08-22 | Boxed warning, Warnings, Adverse reactions | BLA103979 58468-0040 58468-0041 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 58468-0040 | Fabrazyme | AGALSIDASE BETA | Genzyme Corporation | BLA | Current |
| 58468-0040 | Fabrazyme | AGALSIDASE BETA | Genzyme Corporation | BLA | Current |
| 58468-0040 | Fabrazyme | AGALSIDASE BETA | Genzyme Corporation | BLA | Current |
| 58468-0040 | Fabrazyme | AGALSIDASE BETA | Genzyme Corporation | BLA | Current |
| 58468-0040 | Fabrazyme | AGALSIDASE BETA | Genzyme Corporation | BLA | Current |
| 58468-0041 | Fabrazyme | AGALSIDASE BETA | Genzyme Corporation | BLA | Current |
| 58468-0041 | Fabrazyme | AGALSIDASE BETA | Genzyme Corporation | BLA | Current |
| 58468-0041 | Fabrazyme | AGALSIDASE BETA | Genzyme Corporation | BLA | Current |
| 58468-0041 | Fabrazyme | AGALSIDASE BETA | Genzyme Corporation | BLA | Current |
| 58468-0041 | Fabrazyme | AGALSIDASE BETA | Genzyme Corporation | BLA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 79077 | SUPPL | 2024-07-15 |
| 79044 | SUPPL | 2024-07-11 |
| 77416 | SUPPL | 2024-02-07 |
| 77414 | SUPPL | 2024-02-07 |
| 74649 | SUPPL | 2023-06-29 |
| 66769 | SUPPL | 2021-03-12 |
| 66760 | SUPPL | 2021-03-12 |
| 60774 | SUPPL | 2019-11-04 |
| 56934 | SUPPL | 2018-12-21 |
| 56789 | SUPPL | 2018-12-19 |
| 39775 | SUPPL | 2011-01-05 |
| 18727 | SUPPL | 2009-01-16 |
| 31760 | SUPPL | 2008-12-29 |
| 39774 | SUPPL | 2007-01-08 |
| 18726 | SUPPL | 2007-01-08 |
| 18725 | SUPPL | 2007-01-08 |
| 9535 | SUPPL | 2007-01-08 |
| 9534 | SUPPL | 2007-01-08 |
| 9533 | SUPPL | 2007-01-08 |
| 22767 | ORIG | 2004-03-15 |
| 18724 | ORIG | 2004-03-15 |
| 9532 | ORIG | 2004-03-15 |